Research Reports

Key takeaways

Thomas Chan appointed Chief Accounting Officer and principal accounting officer effective immediately on April 23, 2026.

Mr. Chan, age 40, has served as VP Corporate Controller since February 2024 and joined Company in October 2020.

Annual base salary increased to $310,000 with target bonus of 40% of base salary.

RSU award valued at $131,250 vesting quarterly starting August 15, 2026.

PSU award valued at $43,750 vesting in three installments starting March 3, 2027 subject to performance goals.

No family relationships with directors/officers or related party transactions.

Full analysis

The appointment of Thomas Chan as Chief Accounting Officer fills a key financial oversight role, with his internal promotion from Vice President, Corporate Controller signaling continuity in accounting leadership. Mr. Chan's six-year tenure at GoodRx, including progressive controllership roles since 2020, and prior Deloitte experience as Audit Senior Manager provide deep expertise in financial reporting and compliance. Compensation enhancements—including a $310,000 base salary, 40% target bonus, $131,250 RSU vesting quarterly over three years, and performance-tied $43,750 PSU—align incentives with shareholder interests under the 2020 Incentive Award Plan. No disclosed conflicts or family ties ensure clean governance.

GDRX · GoodRx Holdings, Inc.

Summary

Key takeaways

Full analysis